BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 19, Issue 5
  • This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Field of Vision
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2013; 19(5): 631-637
Published online Feb 7, 2013. doi: 10.3748/wjg.v19.i5.631
Table 4 Unresolved issues with prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis
The ideal design of a prophylactic pancreatic stent
Cannulation technique to lower incidence of PEP, tailored to the shape of the major papilla
The ideal pharmacologic agent
Comparison of rectal NSAIDs vs pancreatic stent placement vs combination in high risk patients
The route (rectal or intravenous) and the timing (before or after ERCP) of NSAIDs administration
ERCP: Endoscopic retrograde cholangiopancreatography; PEP: Post-ERCP pancreatitis; NSAIDs: Non-steroidal anti-inflammatory drugs.
Full Size Table
Write to the Help Desk
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.